{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:52:26Z","timestamp":1785455546218,"version":"3.56.0"},"reference-count":112,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":2974,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s13311-015-0353-y","type":"journal-article","created":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T19:43:16Z","timestamp":1428694996000},"page":"631-640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Rett Syndrome: Reaching for Clinical Trials"],"prefix":"10.1016","volume":"12","author":[{"given":"Lucas","family":"Pozzo-Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandipan","family":"Pati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan K.","family":"Percy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-015-0353-y_bib1","first-page":"723","article-title":"On a unusual brain atrophy syndrome in hyperammonemia in childhood","volume":"116","author":"Rett","year":"1966","journal-title":"Wien Med Wochenschr"},{"key":"10.1007\/s13311-015-0353-y_bib2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ana.410140412","article-title":"A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases","volume":"14","author":"Hagberg","year":"1983","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-015-0353-y_bib3","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0387-7604(85)80048-6","article-title":"Rett syndrome: criteria for inclusion and exclusion","volume":"7","author":"Hagberg","year":"1985","journal-title":"Brain Dev"},{"key":"10.1007\/s13311-015-0353-y_bib4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.410230432","article-title":"Diagnostic criteria for Rett syndrome. The Rett Syndrome Diagnostic Criteria Work Group","volume":"23","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-015-0353-y_bib5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1053\/ejpn.2002.0612","article-title":"An update on clinically applicable diagnostic criteria in Rett syndrome. Comments to Rett Syndrome Clinical Criteria Consensus Panel Satellite to European Paediatric Neurology Society Meeting, Baden Baden, Germany, 11 September 2001","volume":"6","author":"Hagberg","year":"2002","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1007\/s13311-015-0353-y_bib6","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/ana.22124","article-title":"Rett syndrome: revised diagnostic criteria and nomenclature","volume":"68","author":"Neul","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-015-0353-y_bib7","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/ana.22154","article-title":"Rett syndrome diagnostic criteria: lessons from the Natural History Study","volume":"68","author":"Percy","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-015-0353-y_bib8","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF00688098","article-title":"Neuropathology of Rett syndrome","volume":"76","author":"Jellinger","year":"1988","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-015-0353-y_bib9","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1055\/s-2007-979736","article-title":"The neuropathology of Rett syndrome\u2014overview 1994","volume":"26","author":"Armstrong","year":"1995","journal-title":"Neuropediatrics"},{"key":"10.1007\/s13311-015-0353-y_bib10","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1177\/08830738050200082401","article-title":"Neuropathology of Rett syndrome","volume":"20","author":"Armstrong","year":"2005","journal-title":"J Child Neurol"},{"key":"10.1007\/s13311-015-0353-y_bib11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0387-7604(12)80194-X","article-title":"Patterns of X chromosome inactivation in the Rett syndrome","volume":"12","author":"Zoghbi","year":"1990","journal-title":"Brain Dev"},{"key":"10.1007\/s13311-015-0353-y_bib12","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/515525","article-title":"A new Rett syndrome family consistent with X-linked inheritance expands the X chromosome exclusion map","volume":"61","author":"Schanen","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1007\/s13311-015-0353-y_bib13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat Genet"},{"key":"10.1007\/s13311-015-0353-y_bib14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/85906","article-title":"Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice","volume":"27","author":"Chen","year":"2001","journal-title":"Nat Genet"},{"key":"10.1007\/s13311-015-0353-y_bib15","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/85899","article-title":"A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome","volume":"27","author":"Guy","year":"2001","journal-title":"Nat Genet"},{"key":"10.1007\/s13311-015-0353-y_bib16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0896-6273(02)00768-7","article-title":"Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3","volume":"35","author":"Shahbazian","year":"2002","journal-title":"Neuron"},{"key":"10.1007\/s13311-015-0353-y_bib17","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.1138389","article-title":"Reversal of neurological defects in a mouse model of Rett syndrome","volume":"315","author":"Guy","year":"2007","journal-title":"Science"},{"key":"10.1007\/s13311-015-0353-y_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0387-7604(12)80169-0","article-title":"The Rett syndrome: gross motor disability and neural impairment in adults","volume":"12","author":"Witt-Engerstrom","year":"1990","journal-title":"Brain Dev"},{"key":"10.1007\/s13311-015-0353-y_bib19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1651-2227.1992.tb12196.x","article-title":"Rett syndrome: the late infantile regression period--a retrospective analysis of 91 cases","volume":"81","author":"Engerstrom","year":"1992","journal-title":"Acta Pediatr"},{"key":"10.1007\/s13311-015-0353-y_bib20","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1136\/jmg.33.8.693","article-title":"Rett syndrome","volume":"33","author":"Clarke","year":"1996","journal-title":"J Med Genet"},{"key":"10.1007\/s13311-015-0353-y_bib21","series-title":"Rett syndrome in Australia","author":"Leonard","year":"1996"},{"key":"10.1007\/s13311-015-0353-y_bib22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jpeds.2005.10.037","article-title":"Rett syndrome in Australia: a review of the epidemiology","volume":"148","author":"Laurvick","year":"2006","journal-title":"J Pediatr"},{"key":"10.1007\/s13311-015-0353-y_bib23","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1203\/01.PDR.0000155945.94249.0A","article-title":"Is the early development of girls with Rett disorder really normal?","volume":"57","author":"Einspieler","year":"2005","journal-title":"Pediatr Res"},{"key":"10.1007\/s13311-015-0353-y_bib24","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.ridd.2013.01.014","article-title":"Changing the perspective on early development of Rett syndrome","volume":"34","author":"Marschik","year":"2013","journal-title":"Res Develop Disabil"},{"key":"10.1007\/s13311-015-0353-y_bib25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1866-1955-6-20","article-title":"Developmental delay in Rett syndrome: data from the natural history study","volume":"6","author":"Neul","year":"2014","journal-title":"J Neurodev Disord"},{"key":"10.1007\/s13311-015-0353-y_bib26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ajmg.1320250503","article-title":"Rett syndrome. History and general overview","volume":"1","author":"Rett","year":"1986","journal-title":"Am J Med Genet Suppl"},{"key":"10.1007\/s13311-015-0353-y_bib27","first-page":"633","article-title":"The pattern of growth failure in Rett syndrome","volume":"147","author":"Schultz","year":"1993","journal-title":"Am J Dis Child"},{"key":"10.1007\/s13311-015-0353-y_bib28","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1212\/WNL.0b013e31826e9a70","article-title":"Growth failure and outcome in Rett syndrome: Specific growth references","volume":"79","author":"Tarquinio","year":"2012","journal-title":"Neurology"},{"key":"10.1007\/s13311-015-0353-y_bib29","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/archneurol.2011.149","article-title":"Rett syndrome: exploring the autism link","volume":"68","author":"Percy","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1007\/s13311-015-0353-y_bib30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0013-4694(97)00084-9","article-title":"Rett syndrome: characterization of seizures versus non-seizures","volume":"106","author":"Glaze","year":"1998","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1007\/s13311-015-0353-y_bib31","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1177\/08830738050200090801","article-title":"Neurophysiology of Rett syndrome","volume":"20","author":"Glaze","year":"2005","journal-title":"J Child Neurol"},{"key":"10.1007\/s13311-015-0353-y_bib32","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1212\/WNL.0b013e3181d6b852","article-title":"Epilepsy and the natural history of Rett syndrome","volume":"74","author":"Glaze","year":"2010","journal-title":"Neurology"},{"key":"10.1007\/s13311-015-0353-y_bib33","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0387-7604(85)80039-5","article-title":"Abnormal breathing in the Rett syndrome","volume":"7","author":"Lugaresi","year":"1985","journal-title":"Brain Dev"},{"key":"10.1007\/s13311-015-0353-y_bib34","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/archneur.1987.00520220051016","article-title":"Rett's syndrome. Correlation of electroencephalographic characteristics with clinical staging","volume":"44","author":"Glaze","year":"1987","journal-title":"Arch Neurol"},{"key":"10.1007\/s13311-015-0353-y_bib35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/adc.85.1.29","article-title":"Characterisation of breathing and associated central autonomic dysfunction in the Rett disorder","volume":"85","author":"Julu","year":"2001","journal-title":"Arch Dis Child"},{"key":"10.1007\/s13311-015-0353-y_bib36","first-page":"31","article-title":"Oropharyngeal dysfunction and gastroesophageal dysmotility are present in girls and women with Rett syndrome","volume":"29","author":"Motil","year":"1999","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1007\/s13311-015-0353-y_bib37","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/MPG.0b013e31818f61fd","article-title":"Gastrostomy placement improves height and weight gain in girls with Rett syndrome","volume":"49","author":"Motil","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1007\/s13311-015-0353-y_bib38","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/MPG.0b013e31824b6159","article-title":"Gastrointestinal and nutritional problems occur frequently throughout life in girls and women with Rett syndrome","volume":"55","author":"Motil","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1007\/s13311-015-0353-y_bib39","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/MPG.0b013e31829e0b65","article-title":"Assessment and management of nutrition and growth in Rett syndrome","volume":"57","author":"Leonard","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1007\/s13311-015-0353-y_bib40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/088307389801300205","article-title":"Hand and foot growth failure in Rett syndrome","volume":"13","author":"Schultz","year":"1998","journal-title":"J Child Neurol"},{"key":"10.1007\/s13311-015-0353-y_bib41","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1203\/PDR.0b013e3181d0187f","article-title":"Profiling scoliosis in Rett syndrome","volume":"67","author":"Percy","year":"2010","journal-title":"Pediatr Res"},{"key":"10.1007\/s13311-015-0353-y_bib42","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1212\/01.wnl.0000291011.54508.aa","article-title":"Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome","volume":"70","author":"Neul","year":"2008","journal-title":"Neurology"},{"key":"10.1007\/s13311-015-0353-y_bib43","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/jmedgenet-2013-102113","article-title":"Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome","volume":"51","author":"Cuddapah","year":"2014","journal-title":"J Med Genet"},{"key":"10.1007\/s13311-015-0353-y_bib44","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1212\/01.wnl.0000304752.50773.ec","article-title":"Investigating genotype-phenotype relationships in Rett syndrome using an international data set","volume":"70","author":"Bebbington","year":"2008","journal-title":"Neurology"},{"key":"10.1007\/s13311-015-0353-y_bib45","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/hmg\/10.17.1729","article-title":"Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry","volume":"10","author":"LaSalle","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-015-0353-y_bib46","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.ejhg.5200618","article-title":"Parental origin of de novo MECP2 mutations in Rett syndrome","volume":"9","author":"Girard","year":"2001","journal-title":"Eur J Hum Genet"},{"key":"10.1007\/s13311-015-0353-y_bib47","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1086\/320109","article-title":"Mecp2 mutations in sporadic cases of rett syndrome are almost exclusively of paternal origin","volume":"68","author":"Trappe","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1007\/s13311-015-0353-y_bib48","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1086\/301932","article-title":"A severely affected male born into a Rett syndrome kindred supports X-linked inheritance and allows extension of the exclusion map","volume":"63","author":"Schanen","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1007\/s13311-015-0353-y_bib49","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11689-009-9034-7","article-title":"Variable phenotypic expression of a MECP2 mutation in a family","volume":"1","author":"Augenstein","year":"2009","journal-title":"J Neurodev Disord"},{"key":"10.1007\/s13311-015-0353-y_bib50","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1212\/01.wnl.0000223318.28938.45","article-title":"Early progressive encephalopathy in boys and MECP2 mutations","volume":"67","author":"Kankirawatana","year":"2006","journal-title":"Neurology"},{"key":"10.1007\/s13311-015-0353-y_bib51","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1086\/302424","article-title":"Rett syndrome in a boy with a 47,XXY karyotype","volume":"64","author":"SalomaoSchwartzman","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1007\/s13311-015-0353-y_bib52","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1212\/WNL.56.11.1486","article-title":"MeCP2 mutations in children with and without the phenotype of Rett syndrome","volume":"56","author":"Hoffbuhr","year":"2001","journal-title":"Neurology"},{"key":"10.1007\/s13311-015-0353-y_bib53","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/088307380101600505","article-title":"Occurrence of Rett syndrome in boys","volume":"16","author":"Leonard","year":"2001","journal-title":"J Child Neurol"},{"issue":"Suppl. 1","key":"10.1007\/s13311-015-0353-y_bib54","doi-asserted-by":"crossref","first-page":"S196","DOI":"10.1016\/S0387-7604(01)00347-3","article-title":"Cytogenetic and molecular-cytogenetic studies of Rett syndrome (RTT): a retrospective analysis of a Russian cohort of RTT patients (the investigation of 57 girls and three boys)","volume":"23","author":"Vorsanova","year":"2001","journal-title":"Brain Dev"},{"key":"10.1007\/s13311-015-0353-y_bib55","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0140-6736(00)02661-1","article-title":"Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males","volume":"356","author":"Clayton-Smith","year":"2000","journal-title":"Lancet"},{"key":"10.1007\/s13311-015-0353-y_bib56","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/sj.ejhg.5201429","article-title":"Disruption of Netrin G1 by a balanced chromosome translocation in a girl with Rett syndrome","volume":"13","author":"Borg","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"10.1007\/s13311-015-0353-y_bib57","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ajmg.a.31133","article-title":"NTNG1 mutations are a rare cause of Rett syndrome","volume":"140","author":"Archer","year":"2006","journal-title":"Am J Med Genet A"},{"key":"10.1007\/s13311-015-0353-y_bib58","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1375\/twin.13.2.168","article-title":"Cyclin-dependent kinase-like 5 (CDKL5) mutation screening in Rett syndrome and related disorders","volume":"13","author":"White","year":"2010","journal-title":"Twin Res Hum Genet"},{"key":"10.1007\/s13311-015-0353-y_bib59","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/s-0032-1308856","article-title":"Variant of Rett syndrome and CDKL5 gene: clinical and autonomic description of 10 cases","volume":"43","author":"Pini","year":"2012","journal-title":"Neuropediatrics"},{"key":"10.1007\/s13311-015-0353-y_bib60","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1469-8749.2012.04432.x","article-title":"Respiratory and sleep disorders in female children with atypical Rett syndrome caused by mutations in the CDKL5 gene","volume":"55","author":"Hagebeuk","year":"2013","journal-title":"Dev Med Child Neurol"},{"key":"10.1007\/s13311-015-0353-y_bib61","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1242\/dmm.011007","article-title":"Preclinical research in Rett syndrome: setting the foundation for translational success","volume":"5","author":"Katz","year":"2012","journal-title":"Dis Model Mech"},{"key":"10.1007\/s13311-015-0353-y_bib62","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1212\/WNL.0b013e3182377dd2","article-title":"Clinical severity and quality of life in children and adolescents with Rett syndrome","volume":"77","author":"Lane","year":"2011","journal-title":"Neurology"},{"key":"10.1007\/s13311-015-0353-y_bib63","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1042\/BST0380498","article-title":"Reversibility of functional deficits in experimental models of Rett syndrome","volume":"38","author":"Cobb","year":"2010","journal-title":"Biochem Soc Trans"},{"key":"10.1007\/s13311-015-0353-y_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20110648","article-title":"MeCP2 and Rett syndrome: reversibility and potential avenues for therapy","volume":"439","author":"Gadalla","year":"2011","journal-title":"Biochem J"},{"key":"10.1007\/s13311-015-0353-y_bib65","doi-asserted-by":"crossref","DOI":"10.2217\/fnl.12.79","article-title":"Recent progress in Rett syndrome and MeCP2 dysfunction: assessment of potential treatment options","volume":"8","author":"Chapleau","year":"2013","journal-title":"Future Neurol"},{"key":"10.1007\/s13311-015-0353-y_bib66","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1073\/pnas.0610593104","article-title":"Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2","volume":"104","author":"Giacometti","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-015-0353-y_bib67","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/mt.2012.200","article-title":"Improved survival and reduced phenotypic severity following AAV9\/MECP2 gene transfer to neonatal and juvenile male Mecp2 knockout mice","volume":"21","author":"Gadalla","year":"2013","journal-title":"Mol Ther"},{"key":"10.1007\/s13311-015-0353-y_bib68","doi-asserted-by":"crossref","first-page":"13612","DOI":"10.1523\/JNEUROSCI.1854-13.2013","article-title":"Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome","volume":"33","author":"Garg","year":"2013","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-015-0353-y_bib69","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00109-010-0704-4","article-title":"Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse model","volume":"89","author":"Brendel","year":"2011","journal-title":"J Mol Med"},{"key":"10.1007\/s13311-015-0353-y_bib70","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ajmg.a.20571","article-title":"Phenotypic manifestations of MECP2 mutations in classical and atypical Rett syndrome","volume":"126A","author":"Schanen","year":"2004","journal-title":"Am J Med Genet A"},{"key":"10.1007\/s13311-015-0353-y_bib71","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1177\/0883073807308715","article-title":"Rett syndrome: North American database","volume":"22","author":"Percy","year":"2007","journal-title":"J Child Neurol"},{"key":"10.1007\/s13311-015-0353-y_bib72","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.clpt.6100012","article-title":"Aminoglycoside-induced translational read-through in disease: overcoming nonsense mutations by pharmacogenetic therapy","volume":"81","author":"Zingman","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1007\/s13311-015-0353-y_bib73","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1002\/jnr.22409","article-title":"Aminoglycoside-mediated partial suppression of MECP2 nonsense mutations responsible for Rett syndrome in vitro","volume":"88","author":"Popescu","year":"2010","journal-title":"J Neurosci Res"},{"key":"10.1007\/s13311-015-0353-y_bib74","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddv030","article-title":"Rett syndrome like phenotypes in the R255X Mecp2 mutant mouse are rescued by MECP2 transgene","author":"Pitcher","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-015-0353-y_bib75","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.cell.2010.10.016","article-title":"A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells","volume":"143","author":"Marchetto","year":"2010","journal-title":"Cell"},{"key":"10.1007\/s13311-015-0353-y_bib76","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1126\/science.1086446","article-title":"Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2","volume":"302","author":"Chen","year":"2003","journal-title":"Science"},{"key":"10.1007\/s13311-015-0353-y_bib77","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1126\/science.1090842","article-title":"DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation","volume":"302","author":"Martinowich","year":"2003","journal-title":"Science"},{"key":"10.1007\/s13311-015-0353-y_bib78","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrn3379","article-title":"Neurotrophin regulation of neural circuit development and function","volume":"14","author":"Park","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"10.1007\/s13311-015-0353-y_bib79","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/978-3-642-45106-5_18","article-title":"Brain-derived neurotrophic factor and Rett syndrome","volume":"220","author":"Katz","year":"2014","journal-title":"Handb Exp Pharmacol"},{"key":"10.1007\/s13311-015-0353-y_bib80","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.neuropharm.2013.03.024","article-title":"BDNF deregulation in Rett syndrome","volume":"76","author":"Li","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1007\/s13311-015-0353-y_bib81","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.neuron.2005.12.027","article-title":"The disease progression of mecp2 mutant mice is affected by the level of BDNF expression","volume":"49","author":"Chang","year":"2006","journal-title":"Neuron"},{"key":"10.1007\/s13311-015-0353-y_bib82","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.nbd.2008.12.011","article-title":"Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations","volume":"34","author":"Larimore","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-015-0353-y_bib83","doi-asserted-by":"crossref","first-page":"14230","DOI":"10.1073\/pnas.1206093109","article-title":"Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome","volume":"109","author":"Deogracias","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-015-0353-y_bib84","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1093\/brain\/awf252","article-title":"Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor","volume":"125","author":"Ziemssen","year":"2002","journal-title":"Brain"},{"key":"10.1007\/s13311-015-0353-y_bib85","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1523\/JNEUROSCI.20-01-00008.2000","article-title":"Positive modulation of AMPA receptors increases neurotrophin expression by hippocampal and cortical neurons","volume":"20","author":"Lauterborn","year":"2000","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-015-0353-y_bib86","doi-asserted-by":"crossref","first-page":"10912","DOI":"10.1523\/JNEUROSCI.1869-07.2007","article-title":"Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome","volume":"27","author":"Ogier","year":"2007","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-015-0353-y_bib87","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1172\/JCI41356","article-title":"Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents","volume":"120","author":"Massa","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1007\/s13311-015-0353-y_bib88","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1523\/JNEUROSCI.0865-11.2012","article-title":"A TrkB small molecule partial agonist rescues TrkB phosphorylation deficits and improves respiratory function in a mouse model of Rett syndrome","volume":"32","author":"Schmid","year":"2012","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-015-0353-y_bib89","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1242\/dmm.016030","article-title":"A BDNF loop-domain mimetic acutely reverses spontaneous apneas and respiratory abnormalities during behavioral arousal in a mouse model of Rett syndrome","volume":"7","author":"Kron","year":"2014","journal-title":"Dis Model Mech"},{"key":"10.1007\/s13311-015-0353-y_bib90","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1172\/JCI27607","article-title":"Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase","volume":"116","author":"Borrell-Pages","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1007\/s13311-015-0353-y_bib91","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1471-4159.2004.02350.x","article-title":"Comparative signaling pathways of insulin-like growth factor-1 and brain-derived neurotrophic factor in hippocampal neurons and the role of the PI3 kinase pathway in cell survival","volume":"89","author":"Zheng","year":"2004","journal-title":"J Neurochem"},{"key":"10.1007\/s13311-015-0353-y_bib92","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1073\/pnas.0812394106","article-title":"Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice","volume":"106","author":"Tropea","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-015-0353-y_bib93","doi-asserted-by":"crossref","first-page":"9941","DOI":"10.1073\/pnas.1311685111","article-title":"Functional recovery with recombinant human IGF1 treatment in a mouse model of Rett Syndrome","volume":"111","author":"Castro","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-015-0353-y_bib94","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1093\/hmg\/ddt111","article-title":"Insulinotropic treatments exacerbate metabolic syndrome in mice lacking MeCP2 function","volume":"22","author":"Pitcher","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-015-0353-y_bib95","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neulet.2012.05.029","article-title":"Insulin-like growth factor 1 (IGF1) and its active peptide (1-3)IGF1 enhance the expression of synaptic markers in neuronal circuits through different cellular mechanisms","volume":"520","author":"Corvin","year":"2012","journal-title":"Neurosci Lett"},{"key":"10.1007\/s13311-015-0353-y_bib96","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1073\/pnas.1311141111","article-title":"Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome","volume":"111","author":"Khwaja","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-015-0353-y_bib97","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF02098506","article-title":"Reduced concentrations and increased metabolism of biogenic amines in a single case of Rett-syndrome: a postmortem brain study","volume":"68","author":"Brucke","year":"1987","journal-title":"J Neural Transm"},{"key":"10.1007\/s13311-015-0353-y_bib98","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0887-8994(89)90049-0","article-title":"Rett syndrome: biogenic amines and metabolites in postmortem brain","volume":"5","author":"Lekman","year":"1989","journal-title":"Pediatr Neurol"},{"key":"10.1007\/s13311-015-0353-y_bib99","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neulet.2008.09.045","article-title":"Tyrosine hydroxylase deficit in the chemoafferent and the sympathoadrenergic pathways of the Mecp2 deficient mouse","volume":"447","author":"Roux","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1007\/s13311-015-0353-y_bib100","doi-asserted-by":"crossref","first-page":"21966","DOI":"10.1073\/pnas.0912257106","article-title":"Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities","volume":"106","author":"Samaco","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-015-0353-y_bib101","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1111\/j.1460-9568.2007.05466.x","article-title":"Treatment with desipramine improves breathing and survival in a mouse model for Rett syndrome","volume":"25","author":"Roux","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.1007\/s13311-015-0353-y_bib102","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.resp.2007.08.009","article-title":"Oral treatment with desipramine improves breathing and life span in Rett syndrome mouse model","volume":"160","author":"Zanella","year":"2008","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1007\/s13311-015-0353-y_bib103","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/mp.2009.80","article-title":"The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation","volume":"15","author":"McEwen","year":"2010","journal-title":"Mol Psychiatry"},{"key":"10.1007\/s13311-015-0353-y_bib104","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1165\/rcmb.2013-0372OC","article-title":"Effect of Sarizotan, a 5-HT1a and D2-like receptor agonist, on respiration in three mouse models of Rett syndrome","volume":"50","author":"Abdala","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1007\/s13311-015-0353-y_bib105","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.neuroscience.2010.03.065","article-title":"Diminished prevalence but preserved synaptic distribution of N-methyl-d-aspartate receptor subunits in the methyl CpG binding protein 2(MeCP2)-null mouse brain","volume":"168","author":"Maliszewska-Cyna","year":"2010","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-015-0353-y_bib106","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1152\/jn.00601.2009","article-title":"MeCP2 is required for normal development of GABAergic circuits in the thalamus","volume":"103","author":"Zhang","year":"2010","journal-title":"J Neurophysiol"},{"key":"10.1007\/s13311-015-0353-y_bib107","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/ar.21380","article-title":"Temporal and regional alterations in NMDA receptor expression in Mecp2-null mice","volume":"294","author":"Blue","year":"2011","journal-title":"Anat Rec"},{"key":"10.1007\/s13311-015-0353-y_bib108","doi-asserted-by":"crossref","first-page":"13860","DOI":"10.1523\/JNEUROSCI.2159-12.2012","article-title":"Brain activity mapping in Mecp2 mutant mice reveals functional deficits in forebrain circuits, including key nodes in the default mode network, that are reversed with ketamine treatment","volume":"32","author":"Kron","year":"2012","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-015-0353-y_bib109","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.neuron.2012.12.004","article-title":"NMDA receptor regulation prevents regression of visual cortical function in the absence of Mecp2","volume":"76","author":"Durand","year":"2012","journal-title":"Neuron"},{"key":"10.1007\/s13311-015-0353-y_bib110","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nature09582","article-title":"Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes","volume":"468","author":"Chao","year":"2010","journal-title":"Nature"},{"key":"10.1007\/s13311-015-0353-y_bib111","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/106002809302700215","article-title":"Vigabatrin","volume":"27","author":"Connelly","year":"1993","journal-title":"Ann Pharmacother"},{"key":"10.1007\/s13311-015-0353-y_bib112","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1749-6632.2012.06611.x","article-title":"The role of oxidative stress in Rett syndrome: an overview","volume":"1259","author":"De Felice","year":"2012","journal-title":"Ann N Y Acad Sci"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-015-0353-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-015-0353-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923016082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923016082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-015-0353-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:09:44Z","timestamp":1761808184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923016082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":112,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1878747923016082"],"URL":"https:\/\/doi.org\/10.1007\/s13311-015-0353-y","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rett Syndrome: Reaching for Clinical Trials","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-015-0353-y","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}